Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
InSightec
AstraZeneca
Alexion Pharmaceuticals, Inc.
AstraZeneca
AstraZeneca
EMD Serono
Bayer
Bayer
Bayer
Novartis
Bayer
Bayer
Bayer
Pfizer
Bayer
AstraZeneca
Astellas Pharma Inc
Pfizer
Bayer
AstraZeneca
Novartis
Bristol-Myers Squibb
Hoffmann-La Roche
Pfizer
Celgene
Takeda
Pfizer
Takeda
Janssen Pharmaceutica N.V., Belgium
Travera Inc
Takeda
Takeda
Hoffmann-La Roche
Janssen-Cilag Ltd.
AbbVie
Janssen-Cilag Ltd.
Janssen Cilag S.A.S.
Janssen-Cilag Ltd.
Novartis
Everest Detection, Inc.
Bayer
Pierre Fabre Ltd
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Cilag S.A.S.
Novartis
Adicet Therapeutics
Pfizer
PinkDx, Inc.
Bayer